BridgeMD
New treatment option for Hematologic Neoplasms
Official title Influenza Vaccination Strategy for Patients With Hematologic Malignancy
ClinicalTrials.gov ID: NCT07485855
What this study is testing
What is High-dose trivalent inactivated influenza vaccine (HD-IIV3)?
High-dose trivalent inactivated influenza vaccine (HD-IIV3) is an investigational medicine, given as an injection into a muscle, being studied as a potential treatment for hematologic neoplasms.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This randomized controlled trial evaluates and compares the immunogenicity of three different influenza vaccine formulations: high-dose trivalent (HD-IIV3), MF59-adjuvanted quadrivalent (aIIV4), and standard-dose trivalent (SD-IIV3) vaccines. The study population consists of patients with hematologic malignancies, including those undergoing autologous stem cell transplantation or CAR-T cell therapy.
- Phase 3: a large, late-stage study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 and older
You may be able to join if
- Adults aged 19 years or older
- Confirmed diagnosis of hematologic malignancy, including: non-Hodgkin lymphoma, Hodgkin lymphoma, acute leukemia, chronic leukemia, or plasma cell...
You likely can't join if
- Difficulty with repeated venipuncture or blood sampling (e.g., poor vascular access or bleeding tendency)
- Cognitive or psychiatric impairment precluding understanding of or cooperation with study procedures
- Known hypersensitivity to influenza vaccine components
- Influenza vaccination within the preceding 6 months
- Any other condition deemed clinically inappropriate for study participation at investigator discretion
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.